Who has invested in InCarda Therapeutics?

Innoviva are named among the investors backing InCarda Therapeutics.

InCarda Therapeutics Funding: $120M Raised, Series C (2020)

InCarda Therapeutics funding overview

InCarda Therapeutics is based in Boston, MA. InCarda Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in October 2020. The round record for InCarda Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Innoviva.

InCarda Therapeutics at a glance

Total raised: $120M
Latest round: Series C
Latest round date: October 2020
Headquarters: Boston, MA
Notable investors: Innoviva

Frequently asked about InCarda Therapeutics funding

How much has InCarda Therapeutics raised?: InCarda Therapeutics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in InCarda Therapeutics?: Innoviva are named among the investors backing InCarda Therapeutics.
What was the latest InCarda Therapeutics funding round?: The most recent disclosed round is a Series C, announced in October 2020.
Where is InCarda Therapeutics based?: InCarda Therapeutics is based in Boston, MA.
When did InCarda Therapeutics last raise?: The last disclosed InCarda Therapeutics round closed in October 2020 at Series C.

Round data for InCarda Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.

InCarda Therapeutics Funding: $120M Raised, Series C (2020)

InCarda Therapeutics funding overview

InCarda Therapeutics at a glance

Frequently asked about InCarda Therapeutics funding

Companies related to InCarda Therapeutics (19)

Browse related funding lists (5)